Mid Atlantic Financial Management’s abrdn Life Sciences Investors HQL Stock Holding History

Mid Atlantic Financial Management’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,700	Closed	-$229K	–	935
2021 Q2	$229K	Buy	+10,700	New	+$216K	0.02%	778
2020 Q3	–	Sell	-11,000	Closed	-$198K	–	776
2020 Q2	$198K	Sell	11,000 -18,500	-63%	-$317K	0.02%	636
2020 Q1	$442K	Buy	29,500 +4,100	+16%	+$67.1K	0.05%	333
2019 Q4	$443K	Sell	25,400 -10,300	-29%	-$169K	0.04%	424
2019 Q3	$539K	Buy	35,700 +6,300	+21%	+$101K	0.06%	330
2019 Q2	$495K	Buy	29,400 +9,700	+49%	+$160K	0.05%	371
2019 Q1	$337K	Buy	19,700 +5,600	+40%	+$96.7K	0.04%	480
2018 Q4	$213K	Buy	+14,100	New	+$248K	0.03%	573

Other funds holding HQL

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Mid Atlantic Financial Management's HQL Position: Q3 2021 in Review

Mid Atlantic Financial Management sold out of abrdn Life Sciences Investors (HQL) in Q3 2021, closing a stake of 10,700 shares — an estimated $229K sold.

Mid Atlantic Financial Management first reported a position in HQL in Q4 2018 and held it in 8 quarters. The position peaked at $539K in Q3 2019. 67 funds tracked by Wall St. Rank hold HQL as of Q3 2021.

Mid Atlantic Financial Management reported no remaining abrdn Life Sciences Investors position as of Q3 2021 after selling out during the quarter.
Mid Atlantic Financial Management sold 10,700 abrdn Life Sciences Investors shares in Q3 2021, an estimated $229K.
Mid Atlantic Financial Management first reported a position in abrdn Life Sciences Investors in Q4 2018 and held it in 8 quarters.
Mid Atlantic Financial Management's abrdn Life Sciences Investors position peaked at $539K in Q3 2019.
67 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.